[1]
2026. COST-UTILITY ANALYSIS OF FENOFIBRATE IN SLOWING PROGRESSION OF DIABETIC RETINOPATHY IN VIETNAM. Vietnam Journal of Community Medicine. 67, CĐ11-NCKH (Aug. 2026). DOI:https://doi.org/10.52163/yhc.v67iCD11.6071.